More Business Wire
View Older Stories View Newer Stories-
Forescout Achieves Service Capability & Performance (SCP) Certification for Second Consecutive Year
-
Western Asset Managed Municipals Fund Inc. Announces Results of Annual Meeting of Stockholders
-
Wilmington PharmaTech Continues Expansion with Significant Investment from Curewell Capital
-
Empower Accelerates Momentum in Stock Plan Services Business
-
Accenture and AWS Accelerate AI-Powered Reinvention and Cloud Modernization for Public Service Organizations
-
New MEMS-based MultiGBASE-T1 FIUs From Pickering Ramp up Test System Bandwidth, Throughput & Operational Life
-
BostonGene Honored with Five 2025 Stevie® Awards for Technology Excellence
-
76 Percent of Organizations Struggle to Match the Speed of AI-Powered Attacks, Finds CrowdStrike State of Ransomware Survey
-
Humana Announces 2026 Medicare Advantage Plans Designed with Veterans in Mind
-
Bidirectional Energy and Wallbox Launch North America’s First Multi-State Bidirectional Charging Program
-
Marcus Corporation Announces Third Quarter Fiscal 2025 Release Date and Conference Call
-
Soluna Appoints Agnes Budzyn to Board of Directors
-
GeoPark Outlines New Long-Term Strategic Plan and Capital Allocation Framework Ahead of 2025 Investor Day
-
Arrowhead Pharmaceuticals Announces Closing of Global License and Collaboration Agreement with Novartis
-
Vince Holding Corp. Debuts on Nasdaq
-
Seaport Entertainment Group Announces Third Quarter 2025 Earnings Release and Conference Call
-
Cape Recognized on 2025 Military + Aerospace Electronics Innovators Awards
-
UGI International Signs Definitive Agreement to Divest its LPG Business in Austria
-
Driven Brands Closes $500 Million Securitization Issuance to Refinance Existing Debt
-
Gilmore Bell Adds New Attorneys in St. Louis
-
The Oasis Group and AdvisorEngine Release Research Report on AI Prospecting Tools
-
Preceptis Medical Selects AcuityMD for Expansion of Breakthrough In-Office Pediatric Ear Tube Device
-
DOCS Dermatology Group Opens New 11,250-Square-Foot Flagship Clinic in Blue Ash, Ohio
-
FDA Clears Access Vascular HydroMid® and HydroPICC® Catheters With Anti-Thrombogenic Indication
-
Team Velocity Recognized as a 2025 Inc. Power Partner Award Winner
-
Silver Storm Commences Rehabilitation Activities at La Parrilla
-
Valmont Reports Third Quarter 2025 Results and Raises Full-Year 2025 Adjusted Earnings per Share Outlook
-
Covalon Declares First Ever Special Cash Dividend
-
SS&C GlobeOp Forward Redemption Indicator
-
Auxia Introduces AI-Native UX That Unifies Decisioning, Content and Insights in One Interface
-
Accel Entertainment, Inc. to Report Third Quarter 2025 Results, Host Conference Call and Webcast on November 4
-
Newleos Therapeutics Appoints Timothy Noyes as President and Chief Executive Officer
-
UL Solutions Sets Date for Third Quarter 2025 Results
-
CDW to Announce Third Quarter 2025 Results on November 4
-
One Equity Partners Acquires Majority Stake in Digital Value
-
GlobalMeet Earns Consecutive Wins for ‘Virtual Event Technology’ in TITAN Business Awards
-
LegalOn Acquires Fides to Streamline Governance for In-House Legal Teams
-
Yelp Expands AI Features to Make Local Discovery More Conversational, Visual and Seamless
-
Satellos Announces First Adult Patient Dosed in LT-001, an Open-Label, Long-Term Follow-Up Study of SAT-3247 in Duchenne Muscular Dystrophy
-
SNAP Benefit Processing Enters AI Era: Hyperscience Unveils Single-Platform Solution to Address Increased H.R.1 Mandates
-
Swimply Expands Beyond Summertime Pools, Launches “Igloos” for Fall and Winter Experiences
-
ReposiTrak to Host Informative Webinar for Produce Suppliers About Food Traceability
-
Intruder’s 2025 Exposure Management Index: SMBs Face Rising Risk as AI Weaponizes Older CVEs
-
Greenflash Launches Energy-Ready Infrastructure for Data Center Growth in Texas
-
Mueller Industries, Inc. Reports Third Quarter 2025 Earnings
-
Iambic Announces Research Collaboration with Jazz Pharmaceuticals for IAM1363 and Zanidatamab Combination Cohort in HER2-Positive Breast Cancer
-
ConcertAI Appoints Dr. Shaalan Beg as Chief Medical Officer, Oncology
-
ActiveCampaign Opens AI Access to All: Active Intelligence Now Available to All Customers With New Agents and Remote MCP
-
GondolaBio Receives U.S. FDA Orphan Drug and Fast Track Designations for PORT-77 for the Treatment of Erythropoietic Protoporphyria (EPP) and X-Linked Protoporphyria (XLP)
-
ACI Worldwide and Prosa Redefine Payments in Latin America with Groundbreaking Infrastructure Upgrade
